HIMS Hims Hers Health Inc
Company Analysis
Latest News
🟢 Hims Hers Health is trading 4.09% up today as healthcare sector gains 1.29%
Hims Hers Health is trading at $33.16 (+4.09%), with the move appearing mainly sector-driven. - Healthcare rose 1.29% during regular trading. - Investors may...
🟢 Hims Hers Health is trading 5.86% up today amid healthcare-sector recovery
Hims Hers Health is trading 5.86% up now at $32.91, with the healthcare-sector recovery appearing to be the clearest explanation. - It gained 13.51% on August...
🟢 Hims Hers Health is trading 11% up today as healthcare stocks rebound after August 18 selloff
Hims Hers Health is trading 10.6% up at $30.28 as healthcare stocks rebound following the August 18 selloff. - Healthcare-sector ETF XLV is up 3.23%,...
🟢 Hims Hers Health is trading 4.7% up today on healthcare-sector gains after August 18 selloff
Hims Hers Health is trading 4.7% up at $28.67 in a rebound alongside a 1.90% healthcare-sector gain supported by positive cancer-vaccine trial news. - Shares...
🔴 Hims Hers Health is trading 4.18% down today on post-earnings margin concerns
Hims Hers Health is trading 4.18% down at $27.41 amid post-earnings concerns over its wider-than-expected second-quarter loss and margin pressure from branded...
🔴 Hims Hers Health is trading 4.1% down today after earnings release showed margin compression
Hims Hers Health is trading 4.1% down now at $29.27 after investors continued selling following the August 10 earnings release. - Revenue beat expectations at...
🔴 Hims Hers Health is trading 4.35% down today after sharply lower margins overshadowed higher revenue guidance
Hims Hers Health is trading 4.35% down at $30.39 after investors focused on the August 10 earnings miss and sharply lower margins. - Second-quarter revenue...
Hims & Hers Bets Big on Branded Weight-Loss Drugs, but Can Investors Stomach the Margin Hit
Shares of Hims & Hers Health tumbled 7.2% to $29.47 after the telehealth company reported a second-quarter loss that blindsided Wall Street, raising hard...
🔴 Hims Hers Health is trading 7.24% down in pre-market after GAAP loss misses expectations
Hims Hers Health is trading 7.24% down at $29.47 after its August 10, 2026 earnings release, as a GAAP loss of $0.37 per share missed the expected $0.05...
🔴 Hims Hers Health is trading 4.5% down in after-hours trading after a $0.37-per-share loss and margin contraction
Hims Hers Health is trading 4.53% down now at $30.33 after its second-quarter 2026 earnings release, with a $0.37-per-share loss and weaker margins driving the...
Hims & Hers beat second quarter revenue estimates but earnings missed amid margin contraction
Hims & Hers Health reported second quarter 2026 revenue of $753.2 million, exceeding consensus estimates by approximately 8%. However, the company posted a...
Hims Hers Health Inc Q2 2026 Earnings Preview: What Analysts Expect on August 10, 2026
Analyst consensus expects Q2 2026 revenue of $698.9 million and an EPS loss of $0.07, with the current stock price of $31.59 trending above the average analyst...
🟢 Hims Hers Health is trading 5% up today after rebounding from FTC lawsuit losses
Hims Hers Health is trading 5.46% up now at $31.32 after rebounding from losses tied to the FTC lawsuit. • The FTC alleges privacy violations, deceptive...
🟢 Hims Hers Health is trading 5.8% up today after rebounding from FTC lawsuit losses
Hims Hers Health is trading 5.8% up at $31.39 after rebounding from losses tied to the Federal Trade Commission lawsuit. - The FTC alleged privacy violations,...
Hims & Hers Bounces Back From FTC Shock — But Can a Company Built on Trust Survive a Privacy Scandal?
Shares shifted sharply upward as Hims & Hers Health clawed back losses from last week's FTC lawsuit, trading at $29.58 — up 6.5% — and extending a rally that...
🔴 Hims Hers Health is trading 4% down today as no clear company-specific catalyst emerges
Hims Hers Health is trading 4.01% down at $30.38 after no clear company-specific catalyst was identified for the August 6, 2026 decline. - The company...
🟢 Hims Hers Health is trading 4% up today as the rebound from the FTC health data privacy selloff continues
Hims Hers Health is trading 4% up at $32.06 as investors extend a rebound from the recent selloff triggered by an FTC health data privacy complaint. - The...
🟢 Hims Hers Health is trading 10.4% up today as investors buy the dip after FTC-driven selloff
Hims Hers Health is trading 10.4% up at $30.65 as investors continue to buy the dip following last week’s sharp selloff triggered by an FTC health data privacy...
🟢 Hims Hers Health is trading 6.5% up today as shares rebound from an FTC-driven selloff
Hims Hers Health is trading 6.5% up at $29.58 as shares rebound from last week’s sharp decline linked to an FTC health data privacy lawsuit. • Investors are...
Hims & Hers faces investor probe, following FTC health data lawsuit
The U.S. Federal Trade Commission (FTC) sued Hims & Hers on July 29, 2026, for allegedly sharing sensitive consumer health information with Meta and Snap. The...